Expand ALLO Menu

ALLO Stock Summary and Trading Ideas (Allogene Therapeutics | NASDAQ:ALLO)

Charts for Today's Stock Price and Implied Volatility in Allogene Therapeutics

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for ALLO by Theoretical Edge and Win Rates



No headlines found.

Trading Statistics

Key Ratios

Allogene Therapeutics (ALLO) Frequently Asked Questions

What does Allogene Therapeutics do?

Allogene Therapeutics Inc is a United States-based clinical stage immuno-oncology company. It is mainly engaged in the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The company is involved in developing a pipeline of multiple allogeneic T cell product candidates utilizing validated gene editing and advanced proprietary cell manufacturing technologies. Its pipeline includes UCART19 which is developed for the treatment of relapsed or refractory acute lymphoblastic leukemia (ALL), as well as several preclinical allogeneic CAR T therapies.

What symbol and exchange does Allogene Therapeutics stock trade?

Allogene Therapeutics trades on the NASDAQ stock market under the symbol ALLO.

What is Allogene Therapeutics stock price doing today?

As of March 28, 2023, ALLO stock price climbed to $5.06 with 190,163 million shares trading.

What is Allogene Therapeutics's Beta?

ALLO has a beta of 1.25, meaning it tends to be more sensitive to market movements. ALLO has a correlation of 0.14 to the broad based SPY ETF.

How much is Allogene Therapeutics worth?

ALLO has a market cap of $729.70 million. This is considered a Small Cap stock.

How much money does Allogene Therapeutics make?

Last quarter Allogene Therapeutics reported $47,000 in Revenue and -$.66 earnings per share. This fell short of revenue expectation by $-13,000 and exceeded earnings estimates by $.04.

What is the highest and lowest price Allogene Therapeutics traded in the last 3 year period?

In the last 3 years, ALLO stock traded as high as $55.00 and as low as $4.91.

What are the top ETFs holding Allogene Therapeutics?

The top ETF exchange traded funds that ALLO belongs to (by Net Assets): XBI, VTI, VB, IWM, VXF.

Is Allogene Therapeutics (ALLO) a good investment?

ALLO has underperformed the market in the last year with a price return of -47.6% while the SPY ETF lost -11.1%. ALLO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -10.0% and -10.0%, respectively, while the SPY returned +4.2% and +3.1%, respectively.

What is the support and resistance for Allogene Therapeutics (ALLO) stock price?

ALLO support price is $4.83 and resistance is $5.23 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALLO stock will trade within this expected range on the day.